Adenovirus-mediated HSV-TK Gene Therapy Using hTERT Promoter in CNE Cells in vitro

被引:0
|
作者
Zhang Yu [1 ,3 ]
Yu Xiang-hui [3 ]
Zha Xiao [1 ,2 ]
Kong Wei [3 ]
机构
[1] Sichuan Tumor Hosp, Dept Radiotherapy, Chengdu 610041, Peoples R China
[2] Sichuan Tumor Hosp, Dept Mol Pharmacol, Chengdu 610041, Peoples R China
[3] Jilin Univ, Coll Life Sci, Vaccine Res Ctr, Changchun 130012, Peoples R China
基金
中国国家自然科学基金;
关键词
hTERT; HSV-TK; Adenovirus; Nasopharyngeal carcinoma; NASOPHARYNGEAL CARCINOMA;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Human telomerase reverse transcriptase(hTERT) activity was detected in human nasopharyngeal carcinoma cell(CNE) but not in human normal lung fibroblast(CCD-11Lu). Recombinant adenoviruses Ad-CMV-TK-enh and Ad-hTERT-TK-enh were constructed and infected into normal fibroblasts and nasopharyngeal carcinoma cells. Ad-CMv-TK-enh with 100 [mu mol/L of ganciclovir(GCV) caused 87% of CCD-11Lu cells death and 91% of CNE cells death, Ad-hTERT-TK-enh with 100 mu mol/L of GCV caused 24% of CCD-11Lu cells death and 79% of CNE cells death. These results indicate that the Ad-hTERT-TK-enh with GCV may be a useful method in suppressing tumor growth in targeted nasopharyngeal carcinoma gene therapy.
引用
收藏
页码:60 / 63
页数:4
相关论文
共 50 条
  • [1] Adenovirus-mediated HSV-TK Gene Therapy Using hTERT Promoter in CNE Cells in vitro
    ZHANG Yu1
    2.Department of Radiotherapy
    Chemical Research in Chinese Universities, 2009, 25 (01) : 60 - 63
  • [2] Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line
    Song, JS
    Kim, HP
    ONCOLOGY REPORTS, 2004, 12 (02) : 443 - 447
  • [3] Combination Adenovirus-Mediated HSV-tk/GCV and Antisense IGF-1 Gene Therapy for Rat Glioma
    李向东
    惠国桢
    卢大儒
    王琪
    徐露
    邱信芳
    薛京伦
    苏州医学院学报, 2000, (07) : 597 - 601
  • [4] In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo
    Okada, T
    Caplen, NJ
    Ramsey, WJ
    Onodera, M
    Shimazaki, K
    Nomot, T
    Ajalli, R
    Wildner, O
    Morris, J
    Kume, A
    Hamada, H
    Blaese, RM
    Ozawa, K
    JOURNAL OF GENE MEDICINE, 2004, 6 (03) : 288 - 299
  • [5] Application of adenovirus-mediated human telomerase catalytic subunit (hTERT) gene promoter in ovarian cancer gene therapy
    Song, JS
    Yoon, WS
    Lee, KW
    Kim, MH
    Kim, KT
    Kim, H
    Kim, YT
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2003, 13 (04) : 517 - 521
  • [6] Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line
    Song, JS
    Kim, HP
    Yoon, WS
    Lee, KW
    Kim, MH
    Kim, KT
    Kim, HS
    Kim, YT
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2003, 67 (11) : 2344 - 2350
  • [7] Combined treatment of cholangiocarcinoma with interventional radiofrequency hyperthermia and heat shock protein promoter-mediated HSV-TK gene therapy
    Luo, Jingfeng
    Zhou, Jiali
    Xie, Fengnan
    Zhu, Yali
    Zhou, Fei
    Zhang, Shuanglin
    Jiang, Shaojie
    He, Jie
    Liu, Jiaxin
    Wu, Xia
    Zhang, Yanhua
    Sun, Jihong
    Yang, Xiaoming
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (08): : 1595 - 1603
  • [8] A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model
    Higashi, Kosuke
    Hazama, Shoichi
    Araki, Atsuhiro
    Yoshimura, Kiyoshi
    Iizuka, Norio
    Yoshino, Shigefumi
    Noma, Takafumi
    Oka, Masaaki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (04) : 1412 - 1420
  • [9] Efficacy of HSV-TK/GCV system suicide gene therapy using SHED expressing modified HSV-TK against lung cancer brain metastases
    Oishi, Tomoya
    Ito, Masahiko
    Koizumi, Shinichiro
    Horikawa, Makoto
    Yamamoto, Taisuke
    Yamagishi, Satoru
    Yamasaki, Tomohiro
    Sameshima, Tetsuro
    Suzuki, Tetsuro
    Sugimura, Haruhiko
    Namba, Hiroki
    Kurozumil, Kazuhiko
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2022, 26 : 253 - 265
  • [10] Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo
    Harvey, T. J.
    Hennig, I. M.
    Shnyder, S. D.
    Cooper, P. A.
    Ingram, N.
    Hall, G. D.
    Selby, P. J.
    Chester, J. D.
    CANCER GENE THERAPY, 2011, 18 (11) : 773 - 784